This letter to the editor addresses the comments by Devakumar et al regarding the long‐term impact of multiple micronutrient supplementation (MMS) during pregnancy. It highlights the significant benefits shown in the individual patient data (IPD) meta‐analysis such as reducing the risk of low birthweight and preterm births, more so among those born to underweight women, reduced neonatal mortality among female infants, reduced 6‐month and infant mortality, with no effect among males, reduced 6‐month mortality among all infants born to anemic mothers. This letter emphasizes the longer term consequences of low birthweight and preterm birth such as increased risk of death not just during infancy but throughout life, reduced lung capacity and immune function as well as an increase in certain cancers and the potential of MMS to mitigate these adverse health outcomes.
